Oncolytics Biotech ONCY Stock
Oncolytics Biotech Price Chart
Oncolytics Biotech ONCY Financial and Trading Overview
| Oncolytics Biotech stock price | 0.51 USD |
| Previous Close | 0.54 USD |
| Open | 0.55 USD |
| Bid | 0.45 USD x 200 |
| Ask | 0.76 USD x 200 |
| Day's Range | 0.53 - 0.55 USD |
| 52 Week Range | 0.53 - 1.32 USD |
| Volume | 676.56K USD |
| Avg. Volume | 1.08M USD |
| Market Cap | 71.79M USD |
| Beta (5Y Monthly) | 1.155 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.35 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.13 USD |
ONCY Valuation Measures
| Enterprise Value | 65.75M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.7881496 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.746 |
Trading Information
Oncolytics Biotech Stock Price History
| Beta (5Y Monthly) | 1.155 |
| 52-Week Change | -55.0000000000000071% |
| S&P500 52-Week Change | 18.50% |
| 52 Week High | 1.32 USD |
| 52 Week Low | 0.53 USD |
| 50-Day Moving Average | 0.77 USD |
| 200-Day Moving Average | 0.9 USD |
ONCY Share Statistics
| Avg. Volume (3 month) | 1.08M USD |
| Avg. Daily Volume (10-Days) | 944.51K USD |
| Shares Outstanding | 131.12M |
| Float | 125.05M |
| Short Ratio | 9.67 |
| % Held by Insiders | 1.65% |
| % Held by Institutions | 9.05% |
| Shares Short | 8.65M |
| Short % of Float | 6.90% |
| Short % of Shares Outstanding | 6.78% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 10:95 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -211.24% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -37649000 USD |
| Net Income Avi to Common (ttm) | -37456000 USD |
| Diluted EPS (ttm) | -0.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.12M USD |
| Total Cash Per Share (mrq) | 0.03 USD |
| Total Debt (mrq) | 448K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.353 |
| Book Value Per Share (mrq) | -0.049 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26704000 USD |
| Levered Free Cash Flow (ttm) | -12010852 USD |
Profile of Oncolytics Biotech
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 4350 Executive Drive |
| ZIP | 92121 |
| Phone | 403 670 7377 |
| Website | https://oncolyticsbiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 29 |
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (GI) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Q&A For Oncolytics Biotech Stock
What is a current ONCY stock price?
Oncolytics Biotech ONCY stock price today per share is 0.51 USD.
How to purchase Oncolytics Biotech stock?
You can buy ONCY shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oncolytics Biotech?
The stock symbol or ticker of Oncolytics Biotech is ONCY.
Which industry does the Oncolytics Biotech company belong to?
The Oncolytics Biotech industry is Biotechnology.
How many shares does Oncolytics Biotech have in circulation?
The max supply of Oncolytics Biotech shares is 131.12M.
What is Oncolytics Biotech Price to Earnings Ratio (PE Ratio)?
Oncolytics Biotech PE Ratio is now.
What was Oncolytics Biotech earnings per share over the trailing 12 months (TTM)?
Oncolytics Biotech EPS is -0.35 USD over the trailing 12 months.
Which sector does the Oncolytics Biotech company belong to?
The Oncolytics Biotech sector is Healthcare.
Oncolytics Biotech ONCY included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27274.47 USD — |
-0.34
|
2.36B USD — | 27240.48 USD — | 27376.66 USD — | — - | 2.36B USD — |
|
US Tech Composite Total Return
XCMP
US
|
33687.81 USD — |
-0.35
|
— — | 33651.16 USD — | 33819.4 USD — | — - | — — |
|
US Tech Capital Market Composite
RCMP
US
|
123.64 USD — |
-1.08
|
— — | 123.4 USD — | 124.6 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1314.51 USD — |
-0.15
|
— — | 1312.06 USD — | 1318.86 USD — | — - | — — |
- {{ link.label }} {{link}}
